Dentsply Sirona (XRAY) Tops Q2 EPS by 17c ; Offers Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.52, $0.17 better than the analyst estimate of $0.35. Revenue for the quarter came in at $898 million versus the consensus estimate of $889.15 million.

FY 2026 Outlook:-

Net sales in the range of $3.5 billion to $3.6 billion vs consensus $3.58 billion.
EPS in the range of $1.40 to $1.50 vs consensus $1.42.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
• Alibaba (BABA) Targets 20gw Of Data Center Capacity By 2032 - Bloomberg